Armstead W M
Departments of Anesthesia and Pharmacology, University of Pennsylvania, Philadelphia 19104, USA.
Peptides. 2001 Jan;22(1):39-46. doi: 10.1016/s0196-9781(00)00354-5.
This study was designed to characterize the role of endothelin-1 (ET-1) in nociceptin/orphanin FQ (NOC/oFQ) induced impairment of NMDA cerebrovasodilation after fluid percussion brain injury (FPI) as a function of age in newborn (1-5 days old) and juvenile (3-4 weeks old) pigs equipped with a closed cranial window. Previous studies have observed that NOC/oFQ is released into CSF and contributes to impaired NMDA induced pial artery dilation following FPI to a greater extent in newborn vs juvenile pigs. Topical ET-1 (10(-10) M), a concentration approximating that observed in CSF following FPI in the newborn, increased CSF NOC/oFQ from 67 +/- 4 to 119 +/- 7 pg/ml under non FPI conditions. CSF NOC/oFQ was elevated within 60 min of FPI (70 +/- 3 to 444 +/- 51 pg/ml) but such release was attenuated by the ET-1 antagonist BQ123 in the newborn (66 +/- 3 to 145 +/- 10 pg/ml). CSF ET-1 and NOC/oFQ were not elevated as greatly in the juvenile following FPI and BQ123 correspondingly did not attenuate CSF NOC/oFQ release as much as in the newborn. Under non injury conditions, ET-1 (10(-10) M) coadministered with NMDA attenuated pial dilation to this excitatory amino acid. Following FPI in the newborn, NMDA (10(-8), 10(-6) M) induced pial artery dilation was reversed to vasoconstriction and both NOC/oFQ and ET-1 receptor antagonists partially prevented such alterations (9 +/- 1 and 16 +/- 1, sham control; -7 +/- 1 and -12 +/- 1, FPI; -2 +/- 1 and -3 +/- 1, FPI-NOC/oFQ antagonist; and 2 +/- 1 and 5 +/- 1 %, FPI-ET-1 antagonist). NMDA induced pial dilation was only attenuated following FPI in the juvenile and modestly restored by NOC/oFQ and ET-1 receptor antagonists. These data show that ET-1, in concentrations present in CSF following FPI, contributes to the release of CSF NOC/oFQ following such an insult. The greater release of such ET-1 following FPI in the newborn contributes to the corresponding greater release of NOC/oFQ in the newborn vs the juvenile. Moreover, ET-1 also contributes to the impairment of NMDA cerebrovasodilation after brain injury to a greater extent in newborns vs juveniles. These data suggest that ET-1 contributes to NOC/oFQ induced impairment of NMDA cerebrovasodilation after brain injury in an age dependent manner.
本研究旨在确定内皮素-1(ET-1)在伤害感受素/孤啡肽FQ(NOC/oFQ)诱导的液压冲击脑损伤(FPI)后NMDA介导的脑血管舒张功能障碍中的作用,该作用是新生(1 - 5日龄)和幼年(3 - 4周龄)猪(配备闭合式颅骨视窗)年龄的函数。先前的研究观察到,NOC/oFQ释放到脑脊液中,并且在新生猪与幼年猪中,FPI后NOC/oFQ对NMDA诱导的软脑膜动脉扩张功能障碍的影响更大。局部应用ET-1(10⁻¹⁰ M),这一浓度接近新生猪FPI后在脑脊液中观察到的浓度,在非FPI条件下可使脑脊液中NOC/oFQ从67±4 pg/ml增加至119±7 pg/ml。FPI后60分钟内脑脊液中NOC/oFQ升高(从70±3 pg/ml至444±51 pg/ml),但在新生猪中ET-1拮抗剂BQ123可减弱这种释放(从66±3 pg/ml至145±10 pg/ml)。FPI后幼年猪脑脊液中ET-1和NOC/oFQ升高幅度不如新生猪大,相应地,BQ123对幼年猪脑脊液中NOC/oFQ释放的减弱程度也不如新生猪。在非损伤条件下,与NMDA共同给药的ET-1(10⁻¹⁰ M)减弱了对这种兴奋性氨基酸的软脑膜扩张反应。新生猪FPI后,NMDA(10⁻⁸、10⁻⁶ M)诱导的软脑膜动脉扩张转变为血管收缩,NOC/oFQ和ET-1受体拮抗剂均可部分阻止这种改变(假手术对照组分别为9±1和16±1;FPI组为 - 7±1和 - 12±1;FPI - NOC/oFQ拮抗剂组为 - 2±1和 - 3±1;FPI - ET-1拮抗剂组为2±1和5±1%)。仅在幼年猪FPI后NMDA诱导的软脑膜扩张减弱,NOC/oFQ和ET-1受体拮抗剂可适度恢复。这些数据表明,FPI后脑脊液中存在的ET-1浓度有助于损伤后脑脊液中NOC/oFQ的释放。FPI后新生猪中这种ET-1的更大释放导致新生猪中NOC/oFQ的释放相应地比幼年猪更大。此外,与幼年猪相比,ET-1在新生猪脑损伤后对NMDA脑血管舒张功能障碍的影响也更大。这些数据表明,ET-1以年龄依赖性方式促成脑损伤后NOC/oFQ诱导的NMDA脑血管舒张功能障碍。